Bank Julius Baer & Co’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,084
| Closed | -$143K | – | 555 |
|
|
2023
Q4 | $143K | Sell |
1,084
-13
| -1% | -$1.71K | ﹤0.01% | 421 |
|
|
2023
Q3 | $123K | Buy |
+1,097
| New | +$123K | ﹤0.01% | 408 |
|
|
2023
Q1 | – | Sell |
-2,474
| Closed | -$295K | – | 604 |
|
|
2022
Q4 | $295K | Buy |
2,474
+794
| +47% | +$94.7K | ﹤0.01% | 388 |
|
|
2022
Q3 | $178K | Buy |
+1,680
| New | +$178K | ﹤0.01% | 412 |
|
|
2022
Q2 | – | Sell |
-150
| Closed | -$14K | – | 621 |
|
|
2022
Q1 | $14K | Buy |
+150
| New | +$14K | ﹤0.01% | 565 |
|